Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sean Gaine (Dublin, Ireland). Who to treat/who not to treat: the "non group I" PH patients. ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease

Member's Comments

No comment yet.

Related content which might interest you: "Can do" versus "do do" in patients with asthma Source: Virtual Congress 2020 – Physical activity and chronic lung disease Year: 2020 Pulmonologists and intensivists: "two hearts are better than one" Source: Eur Respir J 2010; 35: 463-466 Year: 2010 Treatment of OSA in obese children: a "big" issue Source: Annual Congress 2012 - Treatment of paediatric sleep-disordered breathing in special populations Year: 2012 Screening for lung cancer in a high-risk group: but I still haven't found what I'm looking for... Source: Eur Respir J 2007; 29: 6-7 Year: 2007 Difficult-to-wean patients: can we avoid the problem? Source: ERS Skills Course 2016 Year: 2016 Pattern of drug resistance among patients who fail Cat II regimen and patients who fail standard treatment: is there any difference? Source: Eur Respir J 2006; 28: Suppl. 50, 378s Year: 2006 LATE-BREAKING ABSTRACT: The infrequent "frequent" exacerbator: An analysis of the SPIROMICS cohort Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Does "A" stand for alveolization? Source: Eur Respir J 2004; 23: 3-4 Year: 2004 Why your "CV of failures" is always longer than your regular one - and why you should keep trying Source: International Congress 2017 – Early Career Members session Year: 2017 Can " Beta-blockers" be useful to treat asthma? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 How are we going to treat IPF patients in the future? Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges Year: 2013 "INSPIRAÇÃO" study: the COPD patients perspective – a self description of COPD in secondary and primary care in Portugal Source: Eur Respir J 2006; 28: Suppl. 50, 809s Year: 2006 Characteristics of "frequent exacerbators" in mild to moderate COPD patients. Source: International Congress 2018 – COPD around the world Year: 2018 Alveolization: does "A" stand for appropriate morphometry? Source: Eur Respir J 2004; 24: 331-332 Year: 2004 Can we diagnose ILD ? - Yes, we can! Interactive cases Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Can we diagnose ILD ? - Yes, we can! Interactive cases Source: ERS Courses: Interstitial Lung Diseases Year: 2019 "INSPIRAÇÃO" study: a self description of severity, burden and health status in COPD patients in Portugal Source: Eur Respir J 2006; 28: Suppl. 50, 809s Year: 2006